Precedent Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
23,322
+572
+3% +$67K 0.5% 58
2026
Q1
$2.74M Buy
22,750
+775
+4% +$89.5K 0.55% 57
2025
Q4
$2.31M Buy
21,975
+1,947
+10% +$183K 0.49% 67
2025
Q3
$1.68M Buy
20,028
+1,889
+10% +$156K 0.37% 79
2025
Q2
$1.44M Buy
18,139
+3,259
+22% +$259K 0.35% 81
2025
Q1
$1.34M Buy
14,880
+3,221
+28% +$301K 0.37% 80
2024
Q4
$1.16M Buy
11,659
+399
+4% +$41.1K 0.38% 78
2024
Q3
$1.28M Buy
11,260
+2,234
+25% +$265K 0.42% 65
2024
Q2
$1.12M Buy
9,026
+693
+8% +$89.3K 0.45% 61
2024
Q1
$1.1M Buy
8,333
+682
+9% +$84.1K 0.47% 51
2023
Q4
$834K Buy
+7,651
New +$794K 0.42% 62

Other funds holding MRK

Precedent Wealth Partners's MRK Position: Q2 2026 in Review

Precedent Wealth Partners increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $67K and bringing the position to 23,322 shares worth $3M. The position accounts for 0.5% of the portfolio, ranked #58.

Precedent Wealth Partners first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Precedent Wealth Partners held 23,322 shares of Merck worth $3M as of Q2 2026.
  • Precedent Wealth Partners bought 572 Merck shares in Q2 2026, an estimated $67K.
  • Merck made up 0.5% of Precedent Wealth Partners's portfolio in Q2 2026, its #58 holding.
  • Precedent Wealth Partners first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Precedent Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.